WallStSmart

Covista Inc. (CVSA)vsGrand Canyon Education Inc (LOPE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 71% more annual revenue ($1.89B vs $1.11B). LOPE leads profitability with a 19.5% profit margin vs 13.4%. CVSA appears more attractively valued with a PEG of 0.81. CVSA earns a higher WallStSmart Score of 67/100 (B-).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0

LOPE

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 9.5Value: 8.7Quality: 7.3
Piotroski: 3/9Altman Z: 7.84
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$106.98

$9.75 premium

UndervaluedFair: $97.23Overvalued
LOPEUndervalued (+12.0%)

Margin of Safety

+12.0%

Fair Value

$182.19

Current Price

$162.45

$19.74 discount

UndervaluedFair: $182.19Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
15.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

LOPE3 strengths · Avg: 9.7/10
Operating MarginProfitability
35.1%10/10

Strong operational efficiency at 35.1%

Altman Z-ScoreHealth
7.8410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
28.2%9/10

Every $100 of equity generates 28 in profit

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

LOPE1 concerns · Avg: 3.0/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bull Case : LOPE

The strongest argument for LOPE centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 19.5% and operating margin at 35.1%. PEG of 1.08 suggests the stock is reasonably priced for its growth.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : LOPE

The primary concerns for LOPE are Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while LOPE is a mature play — different risk/reward profiles.

CVSA carries more volatility with a beta of 0.73 — expect wider price swings.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

LOPE generates stronger free cash flow (123M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (67/100 vs 66/100) and 12.4% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Grand Canyon Education Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Grand Canyon Education, Inc. provides educational services to colleges and universities in the United States. The company is headquartered in Phoenix, Arizona.

Want to dig deeper into these stocks?